orsolya_nagy_cv_2016 jan

2016 Orsolya Nagy MD PhD

CURRICULUM VITAE Orsolya Nagy MD PhD

PROFESSIONAL EXPERIENCE Feb 2013 to present AbbVie Kft. Title: Medical Manager

Responsibilities: • Leading medical affairs (group of four

people: 3 Medical Advisors and 2 MSLs in Immunology and Speciality Care – Neoroscience, Hemato-oncology, Neonatology)

• Responsible for Humira Rheumatology indications as medical advisor

• Biosimilar expert in biosimilar taskforce, member of global taskforce

• Act as Interim Medical Director: May 2015-Jan 2016

• Regional medical CRM champion and Global Publication Network representative

Nov 2008 to Feb 2013 AbbVie (Formerly Abbott Laboratories

(Magyarország) Kft. Title: Senior Medical Advisor Responsibilities:

• 2008 -2009: for nephrology (paricalcitol) and oncology (leuprolide).

• From December 2010 on: rheumatology (adalimumab)

• From April 2011 to Dec 2012: Leader of Change Management / Organization Development Program at Medical Department,

• Awards: President Award (2011), “Best in Class Award” Finalist in 2011 (at global level). 3 additional awards at local level for costumer focus excellence.

1


March 2006 to October 2008 Bristol-Myers Squibb Kft., Budapest Title: Medical Science Manager and Disease Area Specialist for Neuroscience (Abilify) and Immunology (Orencia®).

October 2001-February 2006 Bács-Kiskun County Hospital, Kecskemét, Department Psychiatry (physician, resident for psychiatry)

• Participated in several phase III. and IV. clinical trials with antipsychotics as sub-investigator.

• Took part in scientific research into schizophrenia, neurocognition and provided several scientific presentations at national scientific congresses (including National Congress of Hungarian Psychiatric Association); contributed to scientific publication in both national and international papers.

2003-2005 Psychiatry teacher for graduate nurses (Szent-Györgyi Albert Technical School for Health and University of Szeged, College for Health Workers) EDUCATION 1995-2001 Medical University of Debrecen, Hungary, Summa cum laude

medical doctor degree 2004-2006 Family therapy training 2004 and 2006 GCP training 2007 Biostatistics training 2007 Specialist in psychiatry 2010 PhD degree 2011 CRA training, Biostatistics training 2014 Health Economy 2015 Biostatistics LANGUAGE SKILLS Hungarian: native German: 1994 state language exam oral and written intermediate level English: 2001 state language exam oral and written, intermediate level.

2001 Spoken English for Speakers of Other Language, Higher Intermediate (Pitman Qualifications) 2008 Advanced level, written, Trinity and state

COMPUTER SKILLS Windows XP and 7 and applications: Word for Windows, Power Point, Excel, Publisher

Acrobat Adobe Professional

SOFT SKILLS

2


Trainings taken: • Strategic Brand Planning (2015, C.E.L. for Pharma) • Business Acumen For MSLs (2014, C.E.L. for Pharma) • DiSC (2012, Béres Ágnes) • Situative Leadership (2012, Management Development Institute) • Time Management (2011, Network Solution) • Change management and Organization development (2010-12, Donáth Attila) • Project management (2011, Csanádi Péter) • Executive-Ready Presentations Skills (2010, Communispond) • Negotiations skills (Develor, 2008) • Presentation skills (2008) • Communication skills (2008) • Leadership skills (Ad Sidera, 2007) • Advanced Power Point (IQSOFT - John Bryce, 2007)

DRIVING LICENSE Class ''B'' driving license, clean SCIENTIFIC WORKS Written publications:

1. Szűcs A., Nagy O., Kákonyi Z., Mlinarics R.: Sürgőssági .pszichiátriai ellátás a háziorvosi gyakorlatban. Háziorvos Továbbképző Szemle. 2003;7:544-8.

2. Keri S., Nagy O., Kelemen O, Myers CE, Gluck MA: Dissociation between medial temporal lobe and basal ganglia memory systems is schizophrenia. Schizophr.Res 2005. Sep.15;77(2-3):321-8

3. Nagy O., Kelemen O., Pataki M., Erdélyi R., Janka Z., Mark A. Gluck, Catherine E. Myers, Kéri Sz.: Tanult ekvivalencia a szkizofréniában: új módszer a hippocampalis és basalis ganglionokhoz kapcsolódó memóriafunkciók mérésére. Psychiatria Hungarica 2005 Dec. 17; 20 (5):363-8.

4. Nagy O, Kelemen O, Benedek G, Myers CE, Shohamy D, Gluck MA, Kéri S. Dopaminergic contribution to cognitive sequence learning. J Neural Transm. 2007;114(5):607-12. Epub 2007 Mar 9.

5. Kelemen O, Nagy O, Mátyássy A, Bitter I, Benedek G, Vidnyánszky Z, Kéri S.: How well do patients with schizophrenia track multiple moving targets? Neuropsychology. 2007 May;21(3):319-25.

6. Polgár P, Farkas M, Nagy O, Kelemen O, Réthelyi J, Bitter I, Myers CE, Gluck MA, Kéri S. [Learning cognitive skills in depression: the effect of context-change] Psychiatr Hung. 2007;22(4):271-5.

7. Polgár P, Farkas M, Nagy O, Kelemen O, Réthelyi J, Bitter I, Myers CE, Gluck MA, Kéri S. How to find the way out from four rooms? The learning of "chaining" associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophr Res. 2008 Feb;99(1-3):200-7.

8. Poór Gy. et al. Evaluation of clinical outcome, treatment compliance and tolerability of adalimumab in patients with active rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis in Hungary: results from EviraEast, a multi-country, multi-center post marketing observational study. Magyar Reumatológia; 2014:55:12-24.

9. Niedermayer D et al. Musculoskeletal ultrasound in routine rheumatology practice: the results of the MUST survey in Hungary. Magyar Reumatológia, 2014; 55: 175-81.

3


Posters & Abstracts:

1. O. Kelemen, O. Nagy, A Máttyássy, I Kiss, Z. Janka, S. Kéri: Do second-generation antipsychotics disrupt decision-making abilities in schizophrenia?. Poster presented: ECNP Congresss, Paris, France, 16-20 Sep 2006. Poster Nr.: P3d002.

2. O. Kelemen - A. Máttyássy - O. Nagy - C. Myers - Z. Janka - M. Gluck - S. Kéri: Basal ganglia and medial temporal lobe memory systems in schizophrenia: the effect of antipsychotics The International of Neuropsychopharmacology. 9; Suppl.1, S148.p., 2006.Poster presented: XXV. CINP Congress, Chicago, 9-13 July 2006.

3. Kéri S, Kelemen O, Nagy O, Vidnyánszky Z, Bitter I, Benedek G. Multiple-object tracking in patients with schizophrenia and in people at high risk of schizophrenia. Schizophrenia Bulletin 2007; 33: 527. Poster presented: 11th International Congress on Schizophrenia Research,Colorado Springs, Colorado, USA. 28 March – 01 April 2007.

4. Nagy Bence, Bowrin Kevin, Lloyd Adam, Mungapen Laura, Van Baardewijk Marc, Kutikova Lucie, Nagy Orsolya, Bánki M. Csaba, Bitter István. Cost-minimalisation analysis of aripiprazole in the treatment of bipolar disorder in Hungary. Poster presented: 15 th Congress of Hungarian Psychiatric Association. Hungary, Debrecen. 28-31 January, 2009.

5. Juhasz P, Danko K, Fazekas K… Nagy O, Gy. Poor: The Impact of the Anti-Cyclic Citrullinated Peptide Antibody Status on the Management of Patients with Early Rheumatoid Arthritis in Hungary: Results from an Interim Analysis. Poster presented at: 8th Central European Congress of Rheumatology, 23-25, September 2010 Sopron, Hungary. Poster Nr P17

6. Géher P. et al. Impaired work productivity of patients with active ankylosing spondylitis and psoriatic arthritis eligible for ADA therapy in Hungary. Poster presented at the 2013 Scientific Congress of Hungarian Association of Rheumatologists, September 26-29, 2013, Debrecen, Hungary

7. Poór Gy. et al. Effectiveness and adherence to adalimumab treatment in patients with RS in Eastern Europe: results of the EviraEAST observational study. Abstract presented at: 15th Annual European League Against Rheumatism (EULAR 2014); June 11-14, 2014; Paris, France. Abstract AB0384.

8. Ratnik K. et al. Data on the impact of anti-citrullinated peptide antibody status (Anti-CCP) on the management of patients with early rheumatoid arthritis. Abstract presented at: 15th Annual European League Against Rheumatism (EULAR 2014); June 11-14, 2014; Paris, France. Abstract AB0243

9. Mandl P. et al. Musculosceletal ultrasound as a tool (MUST) in routine rheumatology practice: data from Central and Eastern European countries. Abstract presented at: 15th Annual European League Against Rheumatism (EULAR 2014); June 11-14, 2014; Paris, France. Abstract AB1018.

10. Géher P. et al. Improved clinical outcomes and workability in spondyloarthritides during real-life administration of adalimumab in Hungary. Oral presentation at Congress of Hungarian Association of Rheumatologists (MRE), 2015, 16-18 September, Szeged, Hungary

MEMBERSHIPS

4


Member of Board of Ethical Communication of Pharmaceutical industry Member of Ethical Promotion Working Group of AIPM Hungary Association of Hungarian Rheumatologists and Oncologists Hungarian Psychiatric Association PERSONAL DETAILS Date and place of birth: 31 December 1976, Szabadszállás, Hungary. Married. Hobby: Pilates, cooking, hiking

Budapest 01th of Jan, 2016

5

orsolya_nagy_cv_2016 jan

Documents